Children's Oncology Group's 2023 blueprint for research: Pharmacy
Pediatric Blood and Cancer, ISSN: 1545-5017, Vol: 70, Issue: S6, Page: e30581
2023
- 8Usage
- 7Captures
- 2Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage8
- Abstract Views8
- Captures7
- Readers7
- Mentions2
- News Mentions2
- 2
Most Recent News
Pharmacists to Take the Reins of Leading Clinical Trials for Children’s Oncology Group
To many people, a pharmacist is the busy individual behind the counter at a community pharmacy. The Children’s Oncology Group (COG) has been challenging this
Article Description
Children's Oncology Group (COG) pharmacists and pharmacy technicians from more than 200 COG-member institutions comprise the COG Pharmacy Discipline. Discipline members serve an essential role in the design and execution of COG clinical trials. Core activities include study drug management, study drug access, clinical trial operations, protocol harmonization, and direct patient care. Discipline members are also actively involved in continuing education, membership engagement, and research across other COG committees/domains. Future areas of committed growth for the discipline include pharmacogenomics, pharmacokinetics, pharmacoeconomics, pharmaceutics, and implementation science.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85165289945&origin=inward; http://dx.doi.org/10.1002/pbc.30581; http://www.ncbi.nlm.nih.gov/pubmed/37460409; https://onlinelibrary.wiley.com/doi/10.1002/pbc.30581; https://institutionalrepository.aah.org/allother/576; https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1578&context=allother
Wiley
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know